GEP-NETs
The combination of EVE/LAN can significantly prolong PFS in patients with well-differentiated grade 1/2 GEP-NETs.
A novel auto-segmentation model and radiomics signature may help with preoperative clinical decision-making for GEP-NETs.
The peripheral blood transcriptome of NET patients showed differential enrichment of 30 systemic cancer hallmarks.
A blood-based, non-invasive classifier can serve as an optional tool for conventional methods in the detection of NETs.
Dr. Weinberg provides a recap of all of the GI oncology data of practice-changing potential presented at ESMO 2024.
Cabozantinib continues to demonstrate significant improvement in PFS in extra-pancreatic or pancreatic neuroendocrine tumors.
Advertisement
Expert Interviews on GI Oncology
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.